Fluvastatin Extended-Release Tablets and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Fluvastatin Extended-Release Tablets and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fluvastatin
Brand name: Lescol, Lescol XL
Synonyms: Fluvastatin
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fluvastatin Extended-Release Tablets-Insulin glargine, recombinant Subcutaneous
- Fluvastatin Extended-Release Tablets-Insulin glulisine
- Fluvastatin Extended-Release Tablets-Insulin Glulisine (Cartridges and Pens)
- Fluvastatin Extended-Release Tablets-Insulin Glulisine (Vials)
- Fluvastatin Extended-Release Tablets-Insulin glulisine Subcutaneous
- Fluvastatin Extended-Release Tablets-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Fluvastatin Sodium
- Insulin glargine and lixisenatide Subcutaneous-Fluvirin
- Insulin glargine and lixisenatide Subcutaneous-Fluvirin 2015-2016 Formula
- Insulin glargine and lixisenatide Subcutaneous-Fluvirin injection
- Insulin glargine and lixisenatide Subcutaneous-Fluvoxamine
- Insulin glargine and lixisenatide Subcutaneous-Fluvoxamine ER Capsules